Sanofi-Aventis Expands Aureus Pharma Pact | GenomeWeb

NEW YORK (GenomeWeb News) – Sanofi-Aventis has extended a license agreement with Aureus Pharma for its data-management line, including its latest database tools, for three years, Aureus said today.

Paris-based Aureus said it will provide its new AurScope knowledge databases and will update its existing databases for the drug maker’s R&D programs.

The therapeutic targets in the databases include kinase inhibitors, nuclear receptors, GPCR protein receptors, and drug safety information related to absorption, distribution, metabolism, and excretion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.